Baclofen safety study halted early: what we learned
NCT ID NCT02596763
First seen Jan 04, 2026 · Last updated May 10, 2026 · Updated 15 times
Summary
This study followed 239 adults in France who started taking baclofen for alcohol use disorder. Researchers called participants monthly for a year to track side effects and see how many stopped the drug due to problems. The goal was to better understand the risks of baclofen in real-world use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centres de Soins, d'Accompagnement et de Prévention en Addictologie (CSAPA) Le Cèdre Bleu
Armentières, 59280, France
-
Etablissement Public de Santé Mentale (EPSM)
Lille, 59000, France
-
Hospital Center
Abbeville, 80100, France
-
Hospital Center
Arras, 62000, France
-
Hospital Center
Boulogne, 62200, France
-
Hospital Center
Carvin, 62220, France
-
Hospital Center
Clermont, 60600, France
-
Hospital Center
Dunkirk, 59300, France
-
Hospital Center
Ham, 80400, France
-
Hospital Center
Hazebrouck, 59190, France
-
Hospital Center
Lens, 62300, France
-
Hospital Center
Roubaix, 59100, France
-
Hospital Center
Saint-Amand-les-Eaux, 59230, France
-
Hospital Center
Saint-Pol-sur-Ternoise, 62130, France
-
Hospital Center
Tourcoing, 59200, France
-
Hospital Center
Valenciennes, 59300, France
-
Service d'Aide aux Toxicomanes (SATO-Picardie)
Beauvais, 60000, France
-
University Hospital of Caen
Caen, France
-
University Hospital of Rouen
Rouen, France
Conditions
Explore the condition pages connected to this study.